ACT CAPITAL MANAGEMENT, LLC - Q1 2022 holdings

$94.5 Million is the total value of ACT CAPITAL MANAGEMENT, LLC's 85 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 25.0% .

 Value Shares↓ Weighting
STAA SellSTAAR SURGICAL CO$19,027,000
-19.3%
238,100
-7.7%
20.13%
+18.2%
ARWR SellARROWHEAD PHARMACEUTICALS INC$9,244,000
-33.8%
201,000
-4.5%
9.78%
-3.1%
ARCT SellARCTURUS THERAPEUTICS HLDGS$6,829,000
-61.5%
253,300
-47.2%
7.22%
-43.7%
CLSD SellCLEARSIDE BIOMEDICAL INC$5,630,000
-17.6%
2,458,600
-1.0%
5.96%
+20.6%
NVDA NewNVIDIA CORPORATION$4,229,00015,500
+100.0%
4.47%
KRYS  KRYSTAL BIOTECH INC$3,926,000
-4.9%
59,0000.0%4.15%
+39.3%
SSYS BuySTRATASYS LTD$3,517,000
+53.6%
138,500
+48.1%
3.72%
+124.8%
DVN NewDEVON ENERGY CORP NEW$2,631,00044,500
+100.0%
2.78%
BuyENVVENO MED CORP$2,556,000
+47.7%
401,200
+52.8%
2.70%
+116.1%
LNTH NewLANTHEUS HOLDINGS INC$2,212,00040,000
+100.0%
2.34%
EIGR BuyEIGER BIOPHARMACEUTICALS INC$2,075,000
+152.1%
250,000
+57.7%
2.20%
+268.9%
INMB  INMUNE BIO INC$1,941,000
-17.4%
230,5000.0%2.05%
+20.8%
IDYA  IDEAYA BIOSCIENCES INC$1,941,000
-52.7%
173,5000.0%2.05%
-30.7%
IKT  INHIBIKASE THERAPEUTICS INC$1,593,000
+0.7%
1,076,5000.0%1.68%
+47.3%
ADTN SellADTRAN INC$1,568,000
-40.3%
85,000
-26.1%
1.66%
-12.6%
DOCN BuyDIGITALOCEAN HLDGS INC$1,446,000
+300.6%
25,000
+455.6%
1.53%
+486.2%
 AIRSCULPT TECHNOLOGIES INC$1,389,000
-20.4%
101,5000.0%1.47%
+16.6%
AFMD  AFFIMED N V$1,349,000
-20.9%
308,8000.0%1.43%
+15.7%
ICAD SellICAD INC$1,313,000
-43.7%
294,500
-9.1%
1.39%
-17.7%
FUBO SellFUBOTV INC$1,261,000
-64.7%
192,000
-16.7%
1.33%
-48.4%
NewQUALTEK SERVICES INC$1,137,000354,269
+100.0%
1.20%
MYOV  MYOVANT SCIENCES LTD$1,132,000
-14.4%
85,0000.0%1.20%
+25.3%
AWH  ASPIRA WOMENS HEALTH INC$1,040,000
-41.2%
1,000,0000.0%1.10%
-14.1%
ZETA SellZETA GLOBAL HOLDINGS CORPcl a$924,000
-18.7%
72,500
-46.3%
0.98%
+19.0%
RRC NewRANGE RESOURCES CORP$911,00030,000
+100.0%
0.96%
AUPH SellAURINIA PHARMACEUTICALS INC$836,000
-80.6%
67,500
-64.2%
0.88%
-71.6%
AMZN  AMAZON.COM INC$652,000
-2.2%
2000.0%0.69%
+43.2%
UPST SellUPSTART HLDGS INC$600,000
-29.2%
5,500
-1.8%
0.64%
+3.8%
COIN  COINBASE GLOBAL INC$570,000
-24.7%
3,0000.0%0.60%
+10.2%
CVX SellCHEVRON CORP NEW$570,000
-61.1%
3,500
-72.0%
0.60%
-43.2%
NTRA SellNATERA INC$509,000
-83.2%
12,500
-61.4%
0.54%
-75.4%
CSBR  CHAMPIONS ONCOLOGY INC$508,000
-2.9%
62,5000.0%0.54%
+42.1%
SURF  SURFACE ONCOLOGY INC$501,000
-38.5%
170,5000.0%0.53%
-10.0%
OCX  ONCOCYTE CORPORATION$492,000
-31.3%
330,0000.0%0.52%
+0.6%
LPTX BuyLEAP THERAPEUTICS INC$464,000
-36.4%
265,000
+17.8%
0.49%
-6.8%
GLBE SellGLOBAL-E ONLINE LTD$422,000
-70.4%
12,500
-44.4%
0.45%
-56.7%
BTAI  BIOXCEL THERAPEUTICS INC$418,000
+2.7%
20,0000.0%0.44%
+50.3%
NLTX SellNEOLEUKIN THERAPEUTICS INC$374,000
-63.5%
199,000
-6.4%
0.40%
-46.5%
PDSB  PDS BIOTECHNOLOGY CORP$371,000
-23.7%
60,0000.0%0.39%
+12.0%
SellMATTERPORT INC$325,000
-71.4%
40,000
-27.3%
0.34%
-58.1%
AFRM NewAFFIRM HLDGS INC$324,0007,000
+100.0%
0.34%
SellDRAGANFLY INC$321,000
+0.9%
135,000
-30.8%
0.34%
+47.8%
RYTM  RHYTHM PHARMACEUTICALS INC$317,000
+15.7%
27,5000.0%0.34%
+69.2%
ONCT SellONCTERNAL THERAPEUTICS INC$313,000
-61.7%
225,000
-37.5%
0.33%
-44.0%
IMTX SellIMMATICS N V$300,000
-64.8%
37,500
-40.9%
0.32%
-48.6%
CRDF BuyCARDIFF ONCOLOGY INC$299,000
-51.5%
120,600
+17.7%
0.32%
-29.0%
AUD  AUDACY INCcl a$282,000
+12.4%
97,5000.0%0.30%
+64.6%
BHVN NewBIOHAVEN PHARMACEUTICAL HLDG CO LTD$249,0002,100
+100.0%
0.26%
GRTS BuyGRITSTONE BIO INC$196,000
-61.9%
47,500
+18.8%
0.21%
-44.4%
MDNA  MEDICENNA THERAPEUTICS CORP$195,000
-21.7%
152,5000.0%0.21%
+14.4%
CRIS  CURIS INC$190,000
-50.1%
80,0000.0%0.20%
-26.9%
ADAP  ADAPTIMMUNE THERAPEUTICS PLCsponds adr$185,000
-45.3%
90,0000.0%0.20%
-19.7%
SellLOTTERY COM INC$176,000
-54.8%
56,000
-8.2%
0.19%
-33.8%
MOGO  MOGO INC$160,000
-14.9%
55,0000.0%0.17%
+24.3%
OYST  OYSTER PT PHARMA INC$157,000
-36.4%
13,5000.0%0.17%
-7.3%
MRKR  MARKER THERAPEUTICS INC$156,000
-53.7%
354,4000.0%0.16%
-32.4%
CLRB  CELLECTAR BIOSCIENCES INC$150,000
+4.2%
217,5000.0%0.16%
+52.9%
KERN  AKERNA CORP$146,000
-34.8%
128,0000.0%0.15%
-4.9%
RNAZ  TRANSCODE THERAPEUTICS INC$144,000
+13.4%
50,0000.0%0.15%
+65.2%
AKRO SellAKERO THERAPEUTICS INC$142,000
-50.3%
10,000
-25.9%
0.15%
-27.5%
ENLV  ENLIVEX THERAPEUTICS LTD$140,000
-10.3%
25,0000.0%0.15%
+31.0%
AMPE  AMPIO PHARMACEUTICALS INC$137,000
-17.5%
291,5000.0%0.14%
+20.8%
YCBD  CBDMD INC$130,000
-3.7%
125,0000.0%0.14%
+40.8%
HSDT  HELIUS MED TECHNOLOGIES INC$117,000
-36.1%
35,2630.0%0.12%
-6.1%
CTSO  CYTOSORBENTS CORP$112,000
-23.8%
35,0000.0%0.12%
+11.3%
TIL  INSTIL BIO INC COM$108,000
-36.8%
10,0000.0%0.11%
-8.1%
SIOX SellSIO GENE THERAPIES INC$98,000
-59.0%
146,500
-20.8%
0.10%
-39.9%
SDPI SellSUPERIOR DRILLING PRODS INC$85,000
+7.6%
80,000
-25.6%
0.09%
+57.9%
ATRA  ATARA BIOTHERAPEUTICS INC$85,000
-41.4%
9,2000.0%0.09%
-14.3%
SQZ  SQZ BIOTECHNOLOGIES CO$77,000
-46.2%
16,0000.0%0.08%
-21.4%
TCON  TRACON PHARMACEUTICALS INC$75,000
-5.1%
28,5000.0%0.08%
+38.6%
AVDL  AVADEL PHARMACEUTICALS PLCsponsored adr$72,000
-15.3%
10,5000.0%0.08%
+24.6%
 LOTTERY COM INC*w exp 05/09/2023$61,000
-59.1%
125,0000.0%0.06%
-39.8%
YALA  YALLA GROUP LTDads$60,000
-34.1%
13,5000.0%0.06%
-4.5%
CYT  CYTEIR THERAPEUTICS INC$57,000
-66.7%
15,0000.0%0.06%
-51.6%
BLRX  BIOLINE RX LTDsponsored ads$47,000
-16.1%
27,5000.0%0.05%
+25.0%
SYRS BuySYROS PHARMACEUTICALS INC$42,000
-40.0%
35,000
+62.8%
0.04%
-13.7%
APLT  APPLIED THERAPEUTICS INC$42,000
-76.5%
20,0000.0%0.04%
-65.9%
ARAV BuyARAVIVE INC$34,000
+54.5%
17,500
+75.0%
0.04%
+125.0%
ATNM SellACTINIUM PHARMACEUTICALS INC$33,000
-85.3%
6,500
-82.7%
0.04%
-78.5%
NKTR SellNEKTAR THERAPEUTICS$32,000
-94.8%
6,000
-87.0%
0.03%
-92.4%
GTH  GENETRON HOLDINGS LIMITEDads$16,000
-65.2%
7,5000.0%0.02%
-48.5%
ABNB  AIRBNB INC$9,000
+12.5%
500.0%0.01%
+66.7%
GNCA  GENOCEA BIOSCIENCES INC$6,0000.0%5,0000.0%0.01%
+50.0%
NewAVINGER INC$6,0001,751
+100.0%
0.01%
APVO ExitAPTEVO THERAPEUTICS INC$0-1,500
-100.0%
-0.01%
AVGR ExitAVINGER INC$0-35,000
-100.0%
-0.01%
TMDX ExitTRANSMEDICS GROUP INC$0-1,000
-100.0%
-0.01%
CCJ ExitCAMECO CORP$0-12,000
-100.0%
-0.19%
ExitON HLDNG AGnamen akt a$0-10,500
-100.0%
-0.29%
FANG ExitDIAMONDBACK ENERGY INC$0-4,500
-100.0%
-0.35%
COG ExitCOTERRA ENERGY INC$0-30,000
-100.0%
-0.41%
AVXL ExitANAVEX LIFE SCIENCES CORP$0-33,500
-100.0%
-0.42%
TGTX ExitTG THERAPEUTICS INC$0-33,900
-100.0%
-0.47%
ExitHILLMAN SOLUTIONS CORP$0-65,000
-100.0%
-0.50%
GDRX ExitGOODRX HLDGS INC$0-40,000
-100.0%
-0.94%
PUBM ExitPUBMATIC INC COM CL A$0-45,000
-100.0%
-1.11%
VIR ExitVIR BIOTECHNOLOGY INC$0-58,000
-100.0%
-1.76%
FB ExitMETA PLATFORMS INCcl a$0-7,500
-100.0%
-1.82%
UTHR ExitUNITED THERAPEUTICS CORP$0-13,500
-100.0%
-2.11%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
STAAR SURGICAL CO6Q3 202222.7%
ARROWHEAD PHARMACEUTICALS INC6Q3 202210.1%
ARCTURUS THERAPEUTICS HLDGS6Q3 202212.8%
CLEARSIDE BIOMEDICAL INC6Q3 20227.7%
KRYSTAL BIOTECH INC6Q3 20225.6%
FUBOTV INC6Q3 20224.4%
EIGER BIOPHARMACEUTICALS INC6Q3 20222.4%
ASPIRA WOMENS HEALTH INC6Q3 20223.3%
ICAD INC6Q3 20222.0%
INHIBIKASE THERAPEUTICS INC COM6Q3 20221.7%

View ACT CAPITAL MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ACT CAPITAL MANAGEMENT, LLC Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
HyreCar Inc.December 09, 2020230,0001.3%
SOLIGENIX, INC.February 07, 20201,221,4995.6%
EDISON NATION, INC.April 18, 2019214,4543.8%
Hancock Jaffe Laboratories, Inc.December 26, 2018503,5004.3%
Ampio Pharmaceuticals, Inc.August 10, 20181,210,7851.4%
Xspand Products Lab, Inc.May 09, 2018405,0009.3%
CROSSROADS SYSTEMS INCJune 16, 201759,0534.8%
ALLDIGITAL HOLDINGS, INC.Sold outJanuary 23, 201700.0%
MOBIVITY HOLDINGS CORP.January 06, 20171,734,9164.8%
Akers Biosciences IncJanuary 25, 2016213,5003.9%

View ACT CAPITAL MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2022-11-03
13F-HR2022-08-12
13F-HR2022-05-11
13F-HR2022-02-03
13F-HR2021-11-16
13F-HR2021-08-16
SC 13G/A2020-12-09
SC 13G/A2020-02-10
SC 13G/A2020-02-07
SC 13G/A2020-02-07

View ACT CAPITAL MANAGEMENT, LLC's complete filings history.

Compare quarters

Export ACT CAPITAL MANAGEMENT, LLC's holdings